ENACT Program on Auditory Perception and Function, Cognitive Function and Health-related Q
Although previous studies indicated that tackling hearing loss may have a secondary benefit in improving cognitive function and delaying the onset of dementia, a more integrated care approach to optimize both hearing and cognitive function may be needed for individuals who already developed cognitive decline. To addres
| Condition(s) | Hearing Loss, Cognitive Impairment, Mild |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Although previous studies indicated that tackling hearing loss may have a secondary benefit in improving cognitive function and delaying the onset of dementia, a more integrated care approach to optimize both hearing and cognitive function may be needed for individuals who already developed cognitive decline. To address the dual care needs for PwMCI and hearing impairment, it may be possible to integrate auditory training into cognitive training, as both of them are activity-based and focus on increasing the attention and working memory of an individual to engage in the auditory communication process. Moreover, auditory instruction is one of the core mediums in delivering cognitive training activities. It is highly possible to integrate the auditory training curricular to the corresponding |
| Who can participate | Inclusion Criteria: * Mild cognitive impairment accordingly to the Petersen's criteria * With at least one-side hearing impairment as defined by a score of 2- or 3- digit test greater than the norm value on the integrated Digit-in-Noise (iDIN test) * Has a smartphone to access the online training materials * Not received formal cognitive and auditory training in the past 6 months. * Available of primary caregiver in the family * give consent to participate Exclusion Criteria: * moderate and severe cognitive impairment * Other sensory impairment |
| Ages | 60 Years |
| Sex | All |
| Lead sponsor | The University of Hong Kong |
| Locations | Hong Kong, Hong Kong |
| Start date | 2025-06-04 |
| NCT ID | NCT06955494 |
| Official listing | https://clinicaltrials.gov/study/NCT06955494 |